Inhibition of N-methyl-D-aspartate receptors increases paraoxon-induced apoptosis in cultured neurons

Toxicol Appl Pharmacol. 2005 Oct 1;208(1):57-67. doi: 10.1016/j.taap.2005.01.018.

Abstract

Organophosphorus (OP) compounds, used as insecticides and chemical warfare agents, are potent neurotoxins. We examined the neurotoxic effect of paraoxon (O,O-diethyl O-p-nitrophenyl phosphate), an organophosphate compound, and the role of NMDA receptors as a mechanism of action in cultured cerebellar granule cells. Paraoxon is neurotoxic to cultured rat cerebellar granule cells in a time- and concentration-dependent manner. Cerebellar granule cells are less sensitive to the neurotoxic effects of paraoxon on day in vitro (DIV) 4 than neurons treated on DIV 8. Surprisingly, the N-methyl-D-aspartate (NMDA) receptor antagonist, MK-801, enhances paraoxon-mediated neurotoxicity suggesting that NMDA receptors may play a protective role. Pretreatment with a subtoxic concentration of N-methyl-D-aspartate (NMDA) [100 microM] protects about 40% of the vulnerable neurons that would otherwise die from paraoxon-induced neurotoxicity. Moreover, addition of a neuroprotective concentration of NMDA 3 h after treatment with paraoxon provides the same level of protection. Because paraoxon-mediated neuronal cell death is time-dependent, we hypothesized that apoptosis may be involved. Paraoxon increases apoptosis about 10-fold compared to basal levels. The broad-spectrum caspase inhibitor (Boc-D-FMK) and the caspase-9-specific inhibitor (Z-LEHD-FMK) protect against paraoxon-mediated apoptosis, paraoxon-stimulated caspase-3 activity and neuronal cell death. MK-801 increases, whereas NMDA blocks paraoxon-induced apoptosis and paraoxon-stimulated caspase-3 activity. These results suggest that activation of NMDA receptors protect neurons against paraoxon-induced neurotoxicity by blocking apoptosis initiated by paraoxon.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Amino Acid Chloromethyl Ketones / pharmacology
  • Animals
  • Animals, Newborn
  • Apoptosis / drug effects*
  • Benzyl Compounds / pharmacology
  • Bungarotoxins / pharmacology
  • Caspase 3
  • Caspase Inhibitors
  • Caspases / metabolism
  • Cell Survival / drug effects
  • Cells, Cultured
  • Cerebellar Cortex / cytology
  • Cerebellar Cortex / drug effects
  • Cerebellar Cortex / metabolism
  • Cholinergic Agonists / pharmacology
  • Cholinergic Antagonists / pharmacology
  • Cholinesterase Inhibitors / pharmacology
  • Cysteine Proteinase Inhibitors / pharmacology
  • Dizocilpine Maleate / pharmacology
  • Dose-Response Relationship, Drug
  • Enzyme Activation / drug effects
  • Hippocampus / cytology
  • Hippocampus / drug effects
  • Hippocampus / metabolism
  • Hydrocarbons, Fluorinated / pharmacology
  • N-Methylaspartate / pharmacology
  • Neurons / cytology
  • Neurons / drug effects
  • Neurons / metabolism
  • Paraoxon / pharmacology*
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, N-Methyl-D-Aspartate / antagonists & inhibitors*
  • Receptors, N-Methyl-D-Aspartate / metabolism
  • Time Factors

Substances

  • Amino Acid Chloromethyl Ketones
  • Benzyl Compounds
  • Boc-D-FMK
  • Bungarotoxins
  • Caspase Inhibitors
  • Cholinergic Agonists
  • Cholinergic Antagonists
  • Cholinesterase Inhibitors
  • Cysteine Proteinase Inhibitors
  • Hydrocarbons, Fluorinated
  • Receptors, N-Methyl-D-Aspartate
  • benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
  • N-Methylaspartate
  • Dizocilpine Maleate
  • Casp3 protein, rat
  • Caspase 3
  • Caspases
  • Paraoxon